Exantas Capital (XAN) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Exantas Capital (NYSE:XAN) issued its quarterly earnings data on Tuesday. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.04, Fidelity Earnings reports. The firm had revenue of $14.51 million for the quarter, compared to analyst estimates of $14.60 million. Exantas Capital had a net margin of 54.24% and a negative return on equity of 2.89%.

Shares of NYSE:XAN traded down $0.22 during trading on Thursday, reaching $11.12. The stock had a trading volume of 243,100 shares, compared to its average volume of 195,355. Exantas Capital has a 52 week low of $8.51 and a 52 week high of $12.09. The firm has a market cap of $359.63 million, a price-to-earnings ratio of -12.93 and a beta of 0.90. The company has a quick ratio of 166.86, a current ratio of 166.87 and a debt-to-equity ratio of 2.37.

The company also recently declared a quarterly dividend, which was paid on Friday, October 26th. Stockholders of record on Friday, September 28th were given a $0.15 dividend. This is a positive change from Exantas Capital’s previous quarterly dividend of $0.10. The ex-dividend date of this dividend was Thursday, September 27th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 5.40%. Exantas Capital’s dividend payout ratio (DPR) is currently -69.77%.

Several equities analysts recently weighed in on the stock. ValuEngine raised shares of Exantas Capital from a “hold” rating to a “buy” rating in a research report on Friday, July 6th. JMP Securities raised their price objective on shares of Exantas Capital from $12.00 to $12.50 and gave the company a “market outperform” rating in a research report on Thursday, August 9th. Raymond James assumed coverage on shares of Exantas Capital in a research report on Monday, July 30th. They set an “outperform” rating and a $12.00 price objective on the stock. Finally, BTIG Research assumed coverage on shares of Exantas Capital in a research report on Monday, October 8th. They set a “buy” rating and a $13.00 price objective on the stock.

Exantas Capital Company Profile

Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, such as first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, and commercial mortgage-backed securities.

Featured Article: Cost of Debt

Earnings History for Exantas Capital (NYSE:XAN)

Receive News & Ratings for Exantas Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exantas Capital and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply